Alimentary pharmacology & therapeutics
-
Aliment. Pharmacol. Ther. · Oct 2009
Long-term results of patients with malignant carcinoid syndrome receiving octreotide LAR.
Octreotide LAR is an established treatment for malignant carcinoid syndrome. However, studies with large number of patients and long follow-up are lacking. ⋯ Octreotide LAR treatment provides a sustained symptomatic response in about half of the patients with malignant carcinoid syndrome and contributes to disease stabilization for a longer period than previously described.